Timber pharmaceuticals to host conference call discussing positive topline results from phase 2b control study of congenital ichthyosis for lead asset, tmb-001

Call to be held on monday, november 22nd at 10:00am et
TMBR Ratings Summary
TMBR Quant Ranking